Deal Snapshot
Labcorp to Acquire Vectra Testing Business from Myriad Genetics
Tuesday 04 May 2021

North Carolina, US-based life sciences company Labcorp (NYSE: LH) has agreed to acquire select operating assets and intellectual property from Myriad Genetics (NASDAQ: MYGN) autoimmune business unit, including the Vectra rheumatoid arthritis assay, which will boost Labcorp's rheumatology and autoimmune portfolios, the company said.

The transaction is expected to close by the end of 3Q21. Specific terms of the transaction were not disclosed. Hogan Lovells acted as legal advisor to Labcorp.

Date Published: 04/05/2021